Correlation Between Sinopharm Group and Henry Schein

Can any of the company-specific risk be diversified away by investing in both Sinopharm Group and Henry Schein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinopharm Group and Henry Schein into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinopharm Group Co and Henry Schein, you can compare the effects of market volatilities on Sinopharm Group and Henry Schein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinopharm Group with a short position of Henry Schein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinopharm Group and Henry Schein.

Diversification Opportunities for Sinopharm Group and Henry Schein

0.46

Correlation Coefficient

Sinopharm Group  Henry Schein

Very weak diversification

The 3 months correlation between Sinopharm and Henry is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Sinopharm Group Co and Henry Schein in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Henry Schein and Sinopharm Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinopharm Group Co are associated (or correlated) with Henry Schein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Henry Schein has no effect on the direction of Sinopharm Group i.e., Sinopharm Group and Henry Schein go up and down completely randomly.

Pair Corralation between Sinopharm Group and Henry Schein

Assuming the 90 days horizon Sinopharm Group Co is expected to generate 1.15 times more return on investment than Henry Schein. However, Sinopharm Group is 1.15 times more volatile than Henry Schein. It trades about 0.06 of its potential returns per unit of risk. Henry Schein is currently generating about -0.01 per unit of risk. If you would invest  246.00  in Sinopharm Group Co on October 10, 2024 and sell it today you would earn a total of  4.00  from holding Sinopharm Group Co or generate 1.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sinopharm Group Co  vs.  Henry Schein

Sinopharm Group

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sinopharm Group Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Sinopharm Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Henry Schein

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Henry Schein are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Henry Schein may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Sinopharm Group and Henry Schein

The main advantage of trading using opposite Sinopharm Group and Henry Schein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinopharm Group position performs unexpectedly, Henry Schein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Henry Schein will offset losses from the drop in Henry Schein's long position.

The idea behind Sinopharm Group Co and Henry Schein pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.